Cryopyrin-associated Periodic Syndromes Market: Growth And Forecast 2030 By Delveinsight

By Author: haven smith
Total Articles: 196
Comment this article

DelveInsight’s ‘

The CAPS market report provides current treatment practices, emerging drugs, CAPS market share of the individual therapies, current and forecasted a href=https://www.delveinsight.com/report-store/cryopyrin-associated-periodic-syndromes-caps-market">Cryopyrin-associated Periodic Syndromes Market Size from 2017 to 2030 in the United States. The Report also covers current CAPS treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses underlying potential of the market

Cryopyrin-associated Periodic Syndromes (CAPS) is a group of auto-inflammatory as well as known autosomal dominant disorder that is believed to be caused by owing to mutations in the NLRP3 gene encoding a ...
... protein called cryopyrin. NLRP3 is a part of the inflammasome protein. For initiation of the innate inflammatory response, inflammasome activation is needed.

Other CAPS also cause mutations in NLRP3, which in turn leads to the overproduction of Interleukin beta-1 (IL-1β) CAPS and basically comprises of three diseases that vary with the severity and the system they are involved in. The mode of inheritance is autosomal dominant with variable penetrance (means only one copy of the gene from one parent is sufficient enough to cause this medical condition).

CAPS comprises a group of three disorders, varying with their severity and the organs they tend to affect upon the onset, namely Neonatal Onset Multisystem Inflammatory Disease (NOMID), also called as Chronic Inflammatory Neurological Cutaneous

Articular Syndrome (CINCA), Familial cold auto inflammatory syndrome (FCAS) and Muckle–Wells syndrome (MWS). NOMID is the most severe form of CAPS, along with episodic fever and chills, is accompanied by other associated symptoms like Central Nervous System Inflammation fever bouts (beginning in infancy), followed by rash flare-ups, and elevated joint pain and red eyes.

On the other hand, MWS is an intermediate form of CAPS. In this case, symptoms like frequent rashes starts in infancy or early adolescence. Occasional fever, joint pain, frequent conjunctivitis, gradual hearing loss, and amyloidosis are symptoms of MWS. FCAS, also known as familial cold urticariais is the mildest form of CAPS with fever and other symptoms, the onset of rash flares begins in early childhood or occasionally in early childhood in all FCAS patients.

Hearing loss and Amyloidosis renal disease is rare in FCAS patients. The symptoms and severity of CAPS vary by disease, but some of the sign include, inflammation in multiple organs, hive-like rash, periodic fever and flare-ups, headache, bulging eyes, blindness, hearing loss, vomiting, joint pain, swelling etc.

Other symptoms that are specific to one type of disease include, hive-like rash on exposure to cold or other environmental triggers in FCAS and in MWS, symptoms may come and go.

Read More-